These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21752495)

  • 1. Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model.
    Nikolajsen GN; Jensen MS; West MJ
    Neurobiol Aging; 2011 Nov; 32(11):1927-31. PubMed ID: 21752495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
    Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
    Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical damage to rat cortical axons mimics early Alzheimer's neuronal pathology.
    King CE; Jacobs I; Dickson TC; Vickers JC
    Neuroreport; 1997 May; 8(7):1663-5. PubMed ID: 9189910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
    Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
    Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over expression of amyloid beta-protein reduces the number of neurons in the striatum of APPswe/PS1DeltaE9.
    Richner M; Bach G; West MJ
    Brain Res; 2009 Apr; 1266():87-92. PubMed ID: 19245800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
    DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM
    Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on Alzheimer's disease and the animal disease model--special reference to acetylcholinergic system].
    Ueki A; Taira H; Miyoshi I
    Seishin Shinkeigaku Zasshi; 1989; 91(10):736-50. PubMed ID: 2626496
    [No Abstract]   [Full Text] [Related]  

  • 12. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
    Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice.
    West MJ; Bach G; Søderman A; Jensen JL
    Neurobiol Aging; 2009 Nov; 30(11):1756-76. PubMed ID: 18336954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance.
    Craft TK; Mahoney JH; Devries AC; Sarter M
    Eur J Neurosci; 2005 Jun; 21(11):3117-32. PubMed ID: 15978021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamine and acetylcholine in the rat cerebral cortex with special reference to pathogenetic mechanisms of Alzheimer's disease.
    Shiosaka S; Yamano M; Tsuchiyama M; Kudo Y; Imaizumi K; Tohyama M
    Gerontology; 1991; 37 Suppl 1():17-23. PubMed ID: 1937065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for neurotrophin-3 in targeting developing cholinergic axon projections to cerebral cortex.
    Robertson RT; Baratta J; Yu J; Guthrie KM
    Neuroscience; 2006 Dec; 143(2):523-39. PubMed ID: 17049175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the capillary network of aged APPswe/PS1dE9 transgenic mice.
    Nikolajsen GN; Kotynski KA; Jensen MS; West MJ
    Neurobiol Aging; 2015 Nov; 36(11):2954-2962. PubMed ID: 26364735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease.
    Falangola MF; Dyakin VV; Lee SP; Bogart A; Babb JS; Duff K; Nixon R; Helpern JA
    NMR Biomed; 2007 May; 20(3):343-51. PubMed ID: 17451178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonhuman primates as models for aging and Alzheimer's disease.
    Voytko ML
    Lab Anim Sci; 1998 Dec; 48(6):611-7. PubMed ID: 10090085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.